Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatitis
ADR ID BADD_A02019
ADR Hierarchy
09      Hepatobiliary disorders
09.01      Hepatic and hepatobiliary disorders
09.01.07      Hepatocellular damage and hepatitis NEC
09.01.07.004      Hepatitis
Description INFLAMMATION of the LIVER. [MeSH]
MedDRA Code 10019717
MeSH ID D006505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Hepatitis | Hepatitis in other infectious diseases classified elsewhere | Hepatitis nonicteric | Hepatitis nonspecific | Hepatitis NOS | Hepatitis reactive non-specific | Hepatitis symptom | Hepatitis, unspecified | Nonspecific hepatitis | Hepatitis aggravated | Hepatitis non-icteric | Syncytial giant cell hepatitis | Hepatitis flare | Liver inflammation | Icteric hepatitis | Hepatitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02015Sevoflurane--
BADD_D02022Silvadene--
BADD_D02026Simvastatin0.000083%
BADD_D02028Sirolimus0.000134%
BADD_D02029Sitagliptin0.000106%
BADD_D02031Sitaxentan--
BADD_D02033Sodium aurothiomalate--
BADD_D02053Sofosbuvir0.002032%
BADD_D02058Sorafenib0.000728%
BADD_D02062Sparfloxacin--
BADD_D02066Spironolactone0.000164%
BADD_D02068Stavudine--
BADD_D02076Strontium ranelate--
BADD_D02090Sulfadiazine--
BADD_D02091Sulfamethoxazole--
BADD_D02093Sulfasalazine0.000909%
BADD_D02097Sulindac--
BADD_D02100Sunitinib0.000918%
BADD_D02105Tacrolimus--
BADD_D02111Tamoxifen--
BADD_D02112Tamoxifen citrate--
BADD_D02140Tegaserode--
BADD_D02143Telavancin--
BADD_D02145Telbivudine--
BADD_D02146Telithromycin--
BADD_D02147Telmisartan0.000390%
BADD_D02150Temozolomide0.000280%
BADD_D02154Tenofovir0.007755%
BADD_D02155Tenofovir disoproxil--
BADD_D02156Tenofovir disoproxil fumarate--
The 18th Page    First    Pre   18 19 20 21    Next   Last    Total 21 Pages
ADReCS-Target
ADR Term Drug Name Target